258 related articles for article (PubMed ID: 2429439)
1. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
Coulson BS; Tursi JM; McAdam WJ; Bishop RF
Virology; 1986 Oct; 154(2):302-12. PubMed ID: 2429439
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates.
Coulson BS; Fowler KJ; Bishop RF; Cotton RG
J Virol; 1985 Apr; 54(1):14-20. PubMed ID: 2579249
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus.
Nagesha HS; Brown LE; Holmes IH
J Virol; 1989 Aug; 63(8):3545-9. PubMed ID: 2545925
[TBL] [Abstract][Full Text] [Related]
5. Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism.
Coulson BS
Virology; 1987 Aug; 159(2):209-16. PubMed ID: 2441519
[TBL] [Abstract][Full Text] [Related]
6. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.
Taniguchi K; Urasawa T; Morita Y; Greenberg HB; Urasawa S
J Infect Dis; 1987 Jun; 155(6):1159-66. PubMed ID: 3033090
[TBL] [Abstract][Full Text] [Related]
7. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
Kobayashi N; Taniguchi K; Urasawa S
Arch Virol; 1991; 117(1-2):73-84. PubMed ID: 1706592
[TBL] [Abstract][Full Text] [Related]
8. Determination of rotavirus serotype-specific antibodies in sera by competitive enhanced enzyme immunoassay.
Beards GM; Desselberger U
J Virol Methods; 1989; 24(1-2):103-10. PubMed ID: 2547808
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.
Ciarlet M; Hidalgo M; Liprandi F
Arch Virol; 1996; 141(3-4):601-14. PubMed ID: 8645098
[TBL] [Abstract][Full Text] [Related]
10. Development of a monoclonal antibody specific for serotype 3 rotavirus strains.
Grunert B; Streckert HJ; Liedtke W; Houly C; Mietens C; Werchau H
Eur J Clin Microbiol; 1987 Apr; 6(2):136-41. PubMed ID: 3036497
[TBL] [Abstract][Full Text] [Related]
11. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
Morita Y; Taniguchi K; Urasawa T; Urasawa S
J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
[TBL] [Abstract][Full Text] [Related]
12. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
Taniguchi K; Maloy WL; Nishikawa K; Green KY; Hoshino Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M
J Virol; 1988 Jul; 62(7):2421-6. PubMed ID: 2453680
[TBL] [Abstract][Full Text] [Related]
13. An equine rotavirus (FI-14 strain) which bears both subgroup I and subgroup II specificities on its VP6.
Hoshino Y; Gorziglia M; Valdesuso J; Askaa J; Glass RI; Kapikian AZ
Virology; 1987 Apr; 157(2):488-96. PubMed ID: 2435059
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
[TBL] [Abstract][Full Text] [Related]
15. Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses.
Ward RL; McNeal MM; Clemens JD; Sack DA; Rao M; Huda N; Green KY; Kapikian AZ; Coulson BS; Bishop RF
J Clin Microbiol; 1991 Mar; 29(3):449-56. PubMed ID: 1709945
[TBL] [Abstract][Full Text] [Related]
16. Antigenic analysis of rotavirus isolates using monoclonal antibodies specific for human serotypes 1, 2, 3 and 4, and SA11.
Heath R; Birch C; Gust I
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2455-66. PubMed ID: 3023533
[TBL] [Abstract][Full Text] [Related]
17. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.
Kirkwood CD; Bishop RF; Coulson BS
Arch Virol; 1996; 141(3-4):587-600. PubMed ID: 8645097
[TBL] [Abstract][Full Text] [Related]
18. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.
Hoshino Y; Sereno MM; Midthun K; Flores J; Kapikian AZ; Chanock RM
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8701-4. PubMed ID: 3001716
[TBL] [Abstract][Full Text] [Related]
19. Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
Hoshino Y; Sereno MM; Midthun K; Flores J; Chanock RM; Kapikian AZ
J Clin Microbiol; 1987 Feb; 25(2):290-4. PubMed ID: 2434522
[TBL] [Abstract][Full Text] [Related]
20. VP4 and VP7 typing using monoclonal antibodies.
Coulson BS
Arch Virol Suppl; 1996; 12():113-8. PubMed ID: 9015108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]